Fibroblastic FAP promotes intrahepatic cholangiocarcinoma growth via MDSCs recruitment

Autor: Bingji Li, Wei Yin, Ying-Hong Shi, Yuli Lin, Yan Song, Qian Cai, Haoyang Luo, Xuguang Yang, Wei-Ren Liu, Rui He, Meng-Xin Tian
Rok vydání: 2019
Předmět:
Male
0301 basic medicine
Cancer Research
Angiogenesis
Lymphocyte
Apoptosis
Cholangiocarcinoma
Mice
0302 clinical medicine
Cell Movement
Tumor Microenvironment
Antigens
Ly

Gene knockdown
ICC
intrahepatic cholangiocarcinoma

medicine.diagnostic_test
Chemistry
Serine Endopeptidases
MVD
microvessel density

lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
medicine.anatomical_structure
Gelatinases
Gene Knockdown Techniques
030220 oncology & carcinogenesis
Heterografts
MDSCs
myeloid derived suppression cells

medicine.symptom
EMT
epithelial–mesenchymal transition

STAT3 Transcription Factor
Original article
congenital
hereditary
and neonatal diseases and abnormalities

lcsh:RC254-282
Flow cytometry
03 medical and health sciences
Stroma
Cell Line
Tumor

TAMs
tumor-associated macrophages

Endopeptidases
medicine
Animals
Humans
FAP
fibroblast activation protein

neoplasms
Cell Proliferation
Cell growth
Myeloid-Derived Suppressor Cells
Membrane Proteins
Fibroblasts
Fbs
fibroblasts

digestive system diseases
Desmoplasia
Disease Models
Animal

030104 developmental biology
Bile Duct Neoplasms
Cancer research
Tumor promotion
CAFs
cancer-associated fibroblasts
Zdroj: Neoplasia: An International Journal for Oncology Research, Vol 21, Iss 12, Pp 1133-1142 (2019)
Neoplasia (New York, N.Y.)
ISSN: 1476-5586
DOI: 10.1016/j.neo.2019.10.005
Popis: Desmoplasia is a hallmark of intrahepatic cholangiocarcinoma (ICC), which constitutes a barrier to infiltration of lymphocyte, but not myeloid cells. Given that dense desmoplastic stroma has been reported to be a barrier to infiltration of lymphocyte, but not myeloid cells. We here investigated whether fibroblastic FAP influenced ICC progression via non-T cell-related immune mechanisms. We demonstrated fibroblastic FAP expression was critical for STAT3 activation and CCL2 production, and ICC-CAFs were the primary source of CCL2 in human ICC microenvironment by using ICC-Fbs from six ICC patients. Fibroblastic knockdown of FAP significantly impaired the ability of ICC-CAFs to promote ICC growth, MDSCs infiltration and angiogenesis, which was restored by adding exogenous CCL2. Furthermore, interestingly, the tumor-promoting effect of fibroblastic FAP is dependent on MDSCs via secretion of CCL2, as depletion of Gr-1+ cells reversed the restoring effects of exogenous CCL2 on tumor growth and angiogenesis. In vitro migration assay confirmed that exogenous CCL2 could rescue the impaired ability of ICC-Fbs to attract Gr-1+ cells caused by fibroblastic FAP knockdown. In contrast, fibroblastic FAP knockdown had no effect on ICC cell proliferation and apoptotic resistance. Depletion MDSCs by anti-Gr-1 monoclonal antibody in subcutaneous transplanted tumor model abrogated tumor promotion by ICC-CAFs suggested that the pro-tumor function of Fibroblastic FAP relied on MDSCs. Mechanical, flow cytometry and chamber migration assay were conducted to find Fibroblastic FAP was required by the ability of ICC-CAFs to promote MDSC migration directly. Moreover, fibroblastic FAP knockdown had no effect on cell proliferation and apoptotic resistance. Here, we revealed the T-cell independent mechanisms underlying the ICC-promoting effect of fibroblastic FAP by attracting MDSCs via CCL2, which was mainly attributed to the ability of FAP to attract MDSCs and suggests that specific targeting fibroblastic FAP may represent a promising therapeutic strategy against ICC.
Databáze: OpenAIRE